C-FORWARD is the Second Phase 3 Trial in the Global HCV Development Program; the First Phase 3 Trial, C-BEYOND, is Currently Enrolling Patients in the US and Canada Regimen has Potential Best-in-Class ...
Only about one-third of patients with acute HCV have symptoms, which may include fatigue, anorexia, and myalgias (Pearlman, 2004). Interestingly, these patients are more likely to clear the virus ...
Increased funding for hepatitis C virus (HCV) research and care delivery is needed to support effective programs for vulnerable communities and meet the WHO 2030 targets for HCV elimination. Strategic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results